Other restrictive cardiomyopathy
ICD-10 I42.5 is a billable code used to indicate a diagnosis of other restrictive cardiomyopathy.
Other restrictive cardiomyopathy is a form of heart disease characterized by the stiffening of the heart muscle, which impairs the heart's ability to fill with blood properly. This condition can arise from various underlying causes, including infiltrative diseases such as amyloidosis or sarcoidosis, and can lead to heart failure. Clinically, patients may present with symptoms such as dyspnea, fatigue, and edema due to fluid retention. The anatomy involved primarily includes the myocardium, which becomes rigid, affecting diastolic function. Disease progression can vary, but it often leads to worsening heart failure symptoms and may require advanced management strategies. Diagnostic considerations include echocardiography, cardiac MRI, and sometimes endomyocardial biopsy to identify the underlying cause. Early diagnosis and management are crucial to improving patient outcomes and quality of life.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I42.5 encompasses various forms of restrictive cardiomyopathy not classified elsewhere, including those caused by infiltrative diseases like amyloidosis, radiation therapy effects, and certain genetic disorders. It is essential to identify the underlying cause for appropriate management.
I42.5 should be used when a patient presents with restrictive cardiomyopathy that does not fit the definitions of other specific types, such as hypertrophic or dilated cardiomyopathy. Accurate clinical documentation is vital to support the use of this code.
Documentation should include clinical findings, diagnostic imaging results, and any relevant laboratory tests that indicate the presence of restrictive cardiomyopathy. A clear description of symptoms and the patient's functional status is also necessary.
